BIVALIRUDIN AND PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME: THEORY AND PRACTICE

QR Code

BIVALIRUDIN AND PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME: THEORY AND PRACTICE

This analytical paper presents the key information on the mechanism of action of a direct thrombin inhibitor – bivalirudin. The difference between bivalirudin and unfractionated or low molecular weight heparins, as well as fondaparinux, in terms of the mechanism of action, pharmacokinetics, and phar...

Full description

Saved in:

Bibliographic Details
Main Author:	O. V. Averkov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2012-06-01
Series:	Российский кардиологический журнал
Subjects:	acute coronary syndrome anticoagulants bivalirudin percutaneous coronary interventions
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1236
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

IMMEDIATE RESULTS OF DELAYED PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: S. D. Chevgun, et al.
Published: (2017-12-01)

Acute Coronary Syndrome after Percutaneous Coronary Intervention: State of the Problem and Clinical Practice Data
by: I. S. Egorova, et al.
Published: (2023-01-01)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019-05-01)

Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome
by: M. Yu. Gilyarov, et al.
Published: (2021-05-01)

THE USE OF ENOXAPARIN IN ACUTE CORONARY SYNDROME
by: E. A. Smirnova, et al.
Published: (2017-01-01)

Outcomes of percutaneous coronary intervention in COVID-19-positive acute coronary syndrome patients: a retrospective study in Vietnam
by: Duy Cao Phuong Le, et al.
Published: (2025-07-01)

Choice of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention
by: A. N. Golosova, et al.
Published: (2020-08-01)

Antiplatelet medications in acute coronary syndromes and percutaneous coronary interventions: focus on tirofiban
by: T. A. Batyraliev, et al.
Published: (2008-12-01)

Early discontinuation of dual antiplatelet therapy via acetylsalicylic acid cessation in patients with acute coronary syndrome undergoing percutaneous coronary interventions to reduce the bleeding risk
by: O. V. Averkov
Published: (2021-02-01)

Modern Antiplatelet Therapy for Percutaneous Coronary Intervention. How to Make the Right Choice?
by: T. M. Uskach, et al.
Published: (2020-12-01)

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016-01-01)

Acute coronary syndrome in patients with prior coronary artery bypass grafting. Literature review
by: O. L. Barbarash, et al.
Published: (2022-02-01)

Coronary artery bypass grafting in the treatment of patients with acute coronary syndrome: current evidence base and unresolved issues
by: T. S. Golovina, et al.
Published: (2021-03-01)

INTERRELATION OF TRANSCUTANEOUS CORONARY INTERVENTIONS FOR ACUTE FORMS OF CORONARY HEART DISEASE AND MORTALITY PARAMETERS IN TYUMEN REGION INHABITANTS
by: V. A. Kuznetsov, et al.
Published: (2014-06-01)

Organoprotective Eﬀects of Extracorporeal Membrane Oxygenation and Intra-Aortic Balloon Pump in High-Risk Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome
by: R. A. Kornelyuk, et al.
Published: (2020-03-01)

LIS-3 Acute Coronary Syndrome Registry: Changes in Clinical and Demographic Characteristics and Tactics of Prehospital and Hospital Treatment of Surviving Patients After Acute Coronary Syndrome Over a 4-Year Period
by: S. Yu. Martsevich, et al.
Published: (2020-05-01)

ANTICOAGULANTS IN ACUTE CORONARY SYNDROME
by: I. A. Latfullin, et al.
Published: (2016-01-01)

HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE?
by: I. S. Yavelov, et al.
Published: (2017-09-01)

IMPLEMENTATION OF THE GRACE SCORE IN ACUTE CORONARY SYNDROME WITH RENAL DYSFUNCTION
by: M. V. Zykov, et al.
Published: (2017-12-01)

Anticoagulant therapy in patients with acute coronary syndrome and COVID-19
by: Yu. N. Panina, et al.
Published: (2021-09-01)

UTILIZING ENOXAPARIN IN THE MANAGEMENT OF ACUTE CORONARY SYNDROME
by: O. V. Krikunova, et al.
Published: (2018-03-01)

Рrevention of contrast-induced nephropathy during interventional treatment of acute coronary syndrome
by: L.O. Miakinkova, et al.
Published: (2023-12-01)

CLINICAL ASPECTS OF PATIENT SELECTION FOR CORONARY ANGIOGRAPHY IN NON-ST ELEVATION ACUTE CORONARY SYNDROME
by: K. A. Kireev
Published: (2015-09-01)

Optimal management of patients with ST-segment elevation myocardial infarction with delayed admission to the percutaneous coronary intervention center (more than 12 hours)
by: S. A. Vorontsova, et al.
Published: (2021-10-01)

Application of a Nomogram Model in Predicting Postoperative Delirium Following Percutaneous Coronary Intervention
by: Yaxin Xiong, et al.
Published: (2025-06-01)

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With 3‐Vessel Coronary Artery Disease and Diabetes
by: Ryaan EL‐Andari, et al.
Published: (2025-06-01)

Home-based care post-acute coronary syndrome: A comprehensive review
by: Prafulla Kerkar, et al.
Published: (2025-05-01)

Computed tomography angiography or invasive coronary angiography in patients with lowto intermediate risk acute coronary syndrome — a single-center study
by: K. V. Kuznetsova, et al.
Published: (2024-04-01)

predictors of long-term fatal cardiovascular events after planned percutaneous coronary interventions
by: E. O. Vershinina, et al.
Published: (2018-12-01)

Coronary Artery Aneurysm Post Drug-Coated Balloon Angioplasty
by: Aninka Saboe, MD, et al.
Published: (2025-07-01)

P2Y<sub>12</sub> Receptor Inhibitors in the Treatment of Patients with Acute Coronary Syndrome and Percutaneous Coronary Intervention: Possibilities of Prasugrel
by: N. M. Vorobyeva
Published: (2019-01-01)

APPLICATION OF RIVAROXABAN IN ACUTE CORONARY SYNDROME: EVIDENCE AND CURRENT GUIDELINES
by: O. V. Averkov
Published: (2016-01-01)

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015-09-01)

STATINS IN ACUTE CORONARY SYNDROMES
by: A. L. Alyavi, et al.
Published: (2019-03-01)

Consequences of escalation and de-escalation of double antiplatelet therapy in patients with acute coronary syndrome in real clinical practice
by: R. L. Shamraev, et al.
Published: (2019-04-01)

ROLE OF GENETIC FACTORS IN THE DEVELOPMENT OF CLOPIDOGREL RESISTANCE AMONG PATIENTS REFERRED FOR PERCUTANEOUS CORONARY INTERVENTIONS
by: S. T. Matskeplishvili, et al.
Published: (2013-08-01)

Influence of multimorbidity on the risk of events in men with chronic coronary artery disease after myocardial infarction and percutaneous coronary intervention
by: D. V. Dedov, et al.
Published: (2023-12-01)

TRANSRADIAL APPROACH DURING PERCUTANEOUS CORONARY INTERVENTIONS. PART 1. EVIDENCE BASE FOR APPLYING A TRANSRADIAL APPROACH
by: Sh. T. Zhamgyrchiev, et al.
Published: (2016-06-01)

Vasospastic angina followed by acute coronary syndrome and myocardial infarction: a case report
by: S. A. Chepurnenko, et al.
Published: (2024-05-01)

Rescue Fibrinolysis in STEMI Patients with Failed Primary Percutaneous Coronary Intervention at Hanoi Medical University Hospital
by: Bui Hai Hoang, et al.
Published: (2025-03-01)